NRC Health Treasury Stock, Value, Acquired, Cost Method
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NRC Health treasury stock, value, acquired, cost method for the quarter ending 2026-06-30 was $7.49M, a 29.87% increase year-over-year.
- NRC Health treasury stock, value, acquired, cost method for the quarter ending 2026-03-31 was $1.86M, a 62.59% decline year-over-year.
- NRC Health treasury stock, value, acquired, cost method for the quarter ending 2025-09-30 was $9.36M, a 8.43% increase year-over-year.
- NRC Health treasury stock, value, acquired, cost method for the quarter ending 2025-06-30 was $5.77M.
- NRC Health treasury stock, value, acquired, cost method for fiscal 2025 was $20.69M, a 37.62% decline from fiscal 2024.
- NRC Health treasury stock, value, acquired, cost method for fiscal 2024 was $33.17M, a 61.88% increase from fiscal 2023.
- NRC Health treasury stock, value, acquired, cost method for fiscal 2023 was $20.49M, a 27.12% decline from fiscal 2022.
- NRC Health treasury stock, value, acquired, cost method for fiscal 2022 was $28.12M, a 337.84% increase from fiscal 2021.
| Period end | Treasury Stock, Value, Acquired, Cost Method 3 month | Treasury Stock, Value, Acquired, Cost Method 12 month |
|---|---|---|
| 2026-06-30 | $7.49M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $1.86M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $20.69M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $9.36M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $5.77M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $4.97M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $33.17M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $8.63M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $17.22M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $20.49M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $313.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $1.83M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $1.98M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $28.12M 10-K · filed 2025-03-17 | |
| 2022-09-30 | $3.65M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $15.47M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $6.68M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $6.42M 10-K · filed 2024-02-27 | |
| 2021-03-31 | $1.21M 10-Q · filed 2022-11-04 | |
| 2020-12-31 | $10.00M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $916.00K 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $2.08M 10-Q · filed 2021-11-05 | |
| 2020-03-31 | $4.42M 10-Q · filed 2021-11-05 | |
| 2019-12-31 | $4.72M 10-K · filed 2022-03-04 | |
| 2019-09-30 | $2.06M 10-Q · filed 2020-11-06 | $5.13M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $137.00K 10-Q · filed 2020-11-06 | $3.57M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $1.12M 10-Q · filed 2020-11-06 | $7.79M derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $1.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $7.95M 10-K · filed 2021-03-05 |
| 2018-09-30 | $511.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $4.36M 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $1.27M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $4.12M 10-K · filed 2020-03-06 | |
| 2016-12-31 | $601.00K 10-K · filed 2019-03-08 | |
| 2015-12-31 | $2.17M 10-K · filed 2018-03-14 | |
| 2014-12-31 | $1.25M 10-K · filed 2017-03-03 | |
| 2013-12-31 | $206.00K 10-K · filed 2016-03-04 | |
| 2012-12-31 | -$5.17M 10-K · filed 2015-03-04 | |
| 2011-12-31 | $591.00K 10-K · filed 2014-03-04 | |
| 2010-12-31 | -$463.00K 10-K · filed 2013-03-01 | |
| 2009-12-31 | -$84.00K 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |